Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 3 of 3 citing Kim: Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic.... (0.12 sec) 

C-peptide levels and insulin independence following autologous nonmyeloablative …

- hbi.ir [PDF] 
CEB Couri, MCB Oliveira, ABPL Stracieri, DA Moraes, … - JAMA, 2009 - Am Med Assoc
Context In 2007, the effects of the autologous nonmyeloablative hematopoietic stem cell
transplantation (HSCT) in 15 patients with type 1 diabetes mellitus (DM) were reported. Most
patients became insulin free with ...
Cited by 13 - Related articles - All 4 versions

Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump …


WL Suarez-Pinzon, GS Cembrowski, A Rabinovitch - Diabetologia, 2009 - Springer
Page 1. RESEARCH LETTER Combination therapy with a dipeptidyl peptidase-4 inhibitor and
a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice WL Suarez-Pinzon
& GS Cembrowski & A. Rabinovitch Received: 2 April 2009 /Accepted ...
Related articles - All 2 versions

Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials


CEB Couri, JC Voltarelli - Diabetology and Metabolic Syndrome, 2009 - ukpmc.ac.uk
Stem cell therapy is one of the most promising treatments for the near future. It is expected that
this kind of therapy can ameliorate or even reverse some diseases. With regard to type 1 diabetes,
studies analyzing the therapeutic ...
Related articles - All 3 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google